Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases
Therapeutic targeting of extracellular proteins has attracted huge attention in treating human diseases. The lysyl oxidases (LOXs) are a family of secreted copper-dependent enzymes which initiate the covalent crosslinking of collagen and elastin fibers in the extracellular microenvironment, thereby...
Main Authors: | Nan Yang, Dan-Feng Cao, Xi-Xi Yin, Hong-Hao Zhou, Xiao-Yuan Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332220309847 |
Similar Items
-
The Interactome of Cancer-Related Lysyl Oxidase and Lysyl Oxidase-like Proteins
by: Sylvain D. Vallet, et al.
Published: (2021-12-01) -
The Role of Lysyl Oxidase Enzymes in Cardiac Function and Remodeling
by: Cristina Rodríguez, et al.
Published: (2019-11-01) -
LYSYL OXIDASE (LOX) – A FUTURE NEW ALLY ON THE STAGE OF THE FIGHT AGAINST CANCER
by: Alexandra Totan, et al.
Published: (2019-09-01) -
Molecular Insights Into Lysyl Oxidases in Cartilage Regeneration and Rejuvenation
by: Weiping Lin, et al.
Published: (2020-04-01) -
Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours
by: Yordanos F.I. Setargew, et al.
Published: (2021-01-01)